Visceral Abdominal and Subfascial Femoral Adipose Tissue Have Opposite Associations with Liver Fat in Overweight and Obese Premenopausal Caucasian Women
Table 2
Metabolic syndrome characteristics of the study population (n = 140).
Mean ± SD
Range
Glucose homeostasis
Fasting insulin, IU/mL
8.2 ± 0.3
2.40–17.9
Fasting glycaemia, mg/dL
89.5 ± 0.7
73.0–113.0
Hb A1c, %
4.9 ± 0.4
4.0–7.0
Lipid profile
TC, mg/dL
194.7 ± 3.9
101.0–307.0
HDL-C, mg/dL
54.1 ± 1.1
29.0–91.0
LDL-C, mg/dL
123.5 ± 3.6
45.0–255.0
TC/HDL-C ratio
3.7 ± 1.1
2.0–9.6
LDL-C/HDL-C ratio
2.4 ± 0.1
0.9–6.1
Apo A1/Apo B100 ratio
1.7 ± 0.1
0.8–3.3
Triglycerides, mg/dL
101.5 ± 4.9
32.0–329.0
Blood pressure
Systolic, mm Hg
120.7 ± 1.4
90.0–175.0
Diastolic, mm Hg
75.8 ± 0.9
50.0–101.0
Liver enzymes
ALT, IU/L
18.2 ± 0.5
9.0–43.0
AST, IU/L
16.2 ± 0.6
5.0–44.0
Inflammation
hs-CRP, mg/dL
0.45 ± 0.03
0.03–1.14
Cytokines
IL-6, pg/mL
10.3 ± 0.6
0.8–31.5
TNF-, pg/mL
3.8 ± 0.2
0.9–14.1
Hypercoagulation
PAI-1, ng/mL
21.2 ± 2.0
1.0–100.0
Fibrinogen, mg/dL
369.4 ± 6.5
201.0–552.0
Adipokines
Leptin, ng/mL
32.9 ± 43.3
0.9–167.4
Adiponectin, ng/mL
9.2 ± 6.4
2.9–41.0
Urine
Uric acid, mg/dL
4.4 ± 1.0
2.40–8.50
Microalbuminuria, g/min
2.7 ± 0.7
0.5–89.8
Cortisol, g/day
41.0 ± 1.7
6.0–105.0
Values are means ± SD. Hb A1c, hemoglobin A(1c); TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Apo A1, apolipoprotein A1; Apo B, apolipoprotein B100; ALT, alanine aminotransferase; AST, aspartate aminotransferase; hs-CRP, high-sensitive C-reactive protein; IL-6, interleukin-6; TNF-, tumor necrosis factor-alpha; PAI-1, plasminogen activator inhibitor-1.
